Allen Lutz

On July 10, Bank of America Corp (NYSE: BAC) analyst Allen Lutz published an analyst note on Teladoc Health, Inc (NYSE: TDOC). What Happened: The Bank of America analyst had a Neutral rating on Teladoc with a $42 price objective. Lutz’s analysis came after the company...

A brutal 12 months for Teladoc Health Inc (NYSE: TDOC) went from bad to much worse on Thursday when the stock dropped another 43% after the company reported much larger-than-expected losses in the first quarter and slashed its 2022 guidance. On Wednesday, Teladoc reported a whopping EPS loss of $41...

HealthEquity Inc (NASDAQ: HQY) outperformed third-quarter expectations with a 47-cent bottom-line more than double analyst forecasts. Revenue of $157.1 million also beat consensus estimates of $152.4 million, while EBITDA closed the quarter at $56 million against $43 million forecasts....

Health care savings institution HealthEquity, Inc. (NASDAQ: HQY)'s stock has rallied roughly 30 percent since Bank of America Merrill Lynch initiated coverage of the company in May, leading to a downgrade on valuation Thursday. The Analyst BofA's Allen Lutz downgraded HealthEquity from Buy...